Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
ALVO
Alvotech
$11.44
Chart
$8.33 (+37.33%)
$10.7 (+6.92%)
$13.12 (-12.80%)
$14.05 (-18.58%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
ALVO
Alvotech
Current Price
$11.44
Login to view Alvotech (ALVO) recommendation from the last 90 days from financial news and social media.
Chart
$8.33 (+37.33%)
$10.7 (+6.92%)
$13.12 (-12.80%)
$14.05 (-18.58%)
ALVO Latest Headlines
Alvotech and Advanz Pharma add three more biosimilars to collaboration.
Wed May 28, 2025
Transactions of Managers and Closely Associated Persons. Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons announcing the acquisition of 95000 shares in Alvotech at ISK 1260 per share by Alvogen Lux Holdings S.ár.l. the second largest shareholder in Alvotech. The date of the transaction is May 20 2025. Alvogen Lux Holdings largest shareholders are CVC (40%) Aztiq (30%) and Te
Fri May 23, 2025
Transactions of Managers and Closely Associated Persons. Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons announcing the acquisition of 95000 shares in Alvotech at ISK 1260 per share by Alvogen Lux Holdings S.ár.l. the second largest shareholder in Alvotech. The date of the transaction is May 20 2025. Alvogen Lux Holdings largest shareholders are CVC (40%) Aztiq (30%) and Te
Fri May 23, 2025
Alvotech Announces Successful Listing of Swedish Depository Receipts on Nasdaq Stockholm. Alvotech announced a successful oversubscribed offering of Swedish Depository Receipts commencing trading on Nasdaq Stockholm.
Mon May 19, 2025
Transactions of Managers and Closely Associated Persons. Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons announcing the acquisition of 19988 shares in Alvotech at USD 10.18 per share by Richard Davies Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14 2025.
Fri May 16, 2025
Transactions of Managers and Closely Associated Persons. Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons announcing the acquisition of 19988 shares in Alvotech at USD 10.18 per share by Richard Davies Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14 2025.
Fri May 16, 2025
Alvogen Lux Holdings Acquires 210000 Shares in Alvotech at ISK 1277.38. Alvogen Lux Holdings acquired 210000 shares in Alvotech reported to Luxembourgs CSSF.
Tue May 13, 2025
Alvogen Lux Holdings Acquires 210000 Shares in Alvotech at ISK 1277.38. Alvogen Lux Holdings acquired 210000 shares in Alvotech reported to Luxembourgs CSSF.
Tue May 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ALVO Stock trends
ALVO Stock performance
ALVO Stock analysis
ALVO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
